Clinical Trial Update: The Effect of Ulinastatin on Bronchoalveolar Lavage Fluid of Inflammatory Factors in Patients With Ventilator-associated Pneumonia [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial update on using ulinastatin for ventilator-associated pneumonia, evaluating inflammatory markers in bronchoalveolar lavage fluid in Phase 2 and P…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ventilator-associated Pneumonia

Drugs mentioned

• Ulinastatin (ulinastatin)

Snippet

Sponsor: Shanghai Minhang Central Hospital | Conditions: Ventilator-associated Bacterial Pneumonia, Mechanical Ventilation Complication | Phase 2, Phase 3 | Status: UNKNOWN